119-HR4993
Joe Fiandra Access to Home Infusion Act of 2025
Last action was on 8-19-2025
SenateCurrent status is Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View Official Bill Information at congress.govNo users have voted for/against support on this bill yet. Be the first!
119th CONGRESS
1st Session
H. R. 4993
1. Short title2. Medicare coverage of external infusion pumps and non-self-administrable home infusion drugs1. Short title
This Act may be cited as the "Joe Fiandra Access to Home Infusion Act of 2025".
2. Medicare coverage of external infusion pumps and non-self-administrable home infusion drugs
(a) In general - Section 1861(n) of the Social Security Act (42 U.S.C. 1395x(n)) is amended by adding at the end the following new sentence:
(1) - The prescribing information approved by the Food and Drug Administration for the home infusion drug associated with the pump instructs that the drug should be administered by or under the supervision of a health care professional.
(2) - A qualified home infusion therapy supplier (as defined in subsection (iii)(3)(D)) administers or supervises the administration of the drug or biological in a safe and effective manner in the patient’s home (as defined in subsection (iii)(3)(B)).
(3) - The prescribing information described in paragraph (1) instructs that the drug should be infused at least 12 times per year—
(A) - intravenously or subcutaneously; or
(B) - at infusion rates that the Secretary determines would require the use of an external infusion pump.
(b) Cost sharing notification - The Secretary of Health and Human Services shall ensure that patients are notified of the cost sharing for electing home infusion therapy compared to other applicable settings of care for the furnishing of infusion drugs under the Medicare program.